These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3531384)

  • 1. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy.
    Wozencraft AO; Sayers G; Blackwell JM
    J Exp Med; 1986 Oct; 164(4):1332-7. PubMed ID: 3531384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of macrophage complement and lectin-like receptors in binding Leishmania parasites to host macrophages.
    Blackwell JM
    Immunol Lett; 1985; 11(3-4):227-32. PubMed ID: 3910569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum.
    Blackwell JM; Ezekowitz RA; Roberts MB; Channon JY; Sim RB; Gordon S
    J Exp Med; 1985 Jul; 162(1):324-31. PubMed ID: 3891904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors and recognition mechanisms of Leishmania species.
    Blackwell JM
    Trans R Soc Trop Med Hyg; 1985; 79(5):606-12. PubMed ID: 3006292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle.
    Cooper A; Rosen H; Blackwell JM
    Immunology; 1988 Dec; 65(4):511-4. PubMed ID: 3065216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    Puentes SM; Dwyer DM; Bates PA; Joiner KA
    J Immunol; 1989 Dec; 143(11):3743-9. PubMed ID: 2584716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
    Mosser DM; Edelson PJ
    J Immunol; 1985 Oct; 135(4):2785-9. PubMed ID: 3161950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.
    Russell DG
    Eur J Biochem; 1987 Apr; 164(1):213-21. PubMed ID: 3549304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.
    Ezekowitz RA; Sim RB; Hill M; Gordon S
    J Exp Med; 1984 Jan; 159(1):244-60. PubMed ID: 6319531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes.
    Wilson ME; Pearson RD
    Infect Immun; 1988 Feb; 56(2):363-9. PubMed ID: 2962944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
    Channon JY; Roberts MB; Blackwell JM
    Immunology; 1984 Oct; 53(2):345-55. PubMed ID: 6490087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of C3 in mediating binding and ingestion of group B streptococcus serotype III by murine macrophages.
    Noel GJ; Katz SL; Edelson PJ
    Pediatr Res; 1991 Jul; 30(1):118-23. PubMed ID: 1891276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
    Schlesinger LS; Horwitz MA
    J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3.
    Mosser DM; Wedgwood JF; Edelson PJ
    J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of electron and confocal microscopy in the study of Leishmania-macrophage interactions.
    Rasmusson B; Descoteaux A
    Microsc Microanal; 2004 Oct; 10(5):656-61. PubMed ID: 15525438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.
    Puentes SM; Sacks DL; da Silva RP; Joiner KA
    J Exp Med; 1988 Mar; 167(3):887-902. PubMed ID: 3280727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement interaction with trypanosomatid promastigotes in normal human serum.
    Domínguez M; Moreno I; López-Trascasa M; Toraño A
    J Exp Med; 2002 Feb; 195(4):451-9. PubMed ID: 11854358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.
    Mosser DM; Handman E
    J Leukoc Biol; 1992 Oct; 52(4):369-76. PubMed ID: 1402387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.